Articles published in Medicinal Chemistry have been cited by esteemed scholars and scientists all around the world.
Medicinal Chemistry has got h-index 40, which means every article in Medicinal Chemistry has got 40 average citations.
Following are the list of articles that have cited the articles published in Medicinal Chemistry.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
50 | 41 | 79 | 58 | 37 | 27 | 37 |
Research, Review articles and Editorials |
1 | 3 | 0 | 8 | 12 | 14 | 37 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
39 | 38 | 79 | 50 | 25 | 13 | 0 |
Conference proceedings |
11 | 55 | 16 | 0 | 0 | 15 | 88 |
Citations received as per Google Scholar, other indexing platforms and portals |
7233 | 4195 | 739 | 814 | 819 | 728 | 637 |
Journal total citations count | 6627 |
Journal impact factor | 2.05 |
Journal 5 years impact factor | 16.32 |
Journal cite score | 1.74 |
Journal h-index | 40 |
Journal h-index since 2019 | 32 |
Asif M. A Review on Antitubercular Activity of Some 2-isonicotinoylhydrazinecarboxamide, 5-(pyridin-4-yl)-1, 3, 4-oxadiazol-2-amine, N-(E)-heteroaromatic-isonicotino-hydrazide and 1-(7-chloroquinolin-4-yl)-2-(heteroaromatic) methylene hydrazone derivatives. |
|
Asif M. Mini Review Study of Antitubercular Drugs of Nicotinamide, Thioisonicotinamide and Pyrazinamide Derivatives. |
|
Hussein AA, Sulieman AE, Al Zabadi H, Elhassan AM, Lgaz H. ISSN 0975-413X CODEN (USA): PCHHAX. |
|
Hussein AA, Sulieman AE, Al Zabadi H, Elhassan AM, Lgaz H. ISSN 0975-413X CODEN (USA): PCHHAX. |
|
Asif, Mohammad. "Recent Advances in the Development of Salicylic Acid Analogues as Anti-Tubercular Agents." Recent Advances in the Development of Salicylic 14, no. 34 (2020). |
|
Asif, M. A. "Brief overview on recent advances in the development of anti-tubercular compounds containing different heterocyclic ring systems." Appl. Microbiol. Open Access. 2, no. 04 (2016): 1-14. |
|
Noor, H. N. "?-Carbonic Anhydrase as a Target for Eradication of Mycobacterium tuberculosis." |
|
Ghosh, Prithwish, Na Yeon Kwon, Sangil Han, Saegun Kim, Sang Hoon Han, Neeraj Kumar Mishra, Young Hoon Jung, Sang J. Chung, and In Su Kim. "Site-Selective C–H Alkylation of Diazine N-Oxides Enabled by Phosphonium Ylides." Organic letters 21, no. 16 (2019): 6488-6493. |
|
Asif, Mohammad. "Antitubercular drugs: advances in nitrogen containing heterocyclic compounds and some other derivatives." Journal of Pharmaceutical Chemistry 1, no. 2 (2014): 37-43. |
|
Shchepina, N. E., V. V. Avrorin, G. A. Badun, A. N. Vasyanin, S. N. Shurov, and I. M. Agafonova. "Investigation of ion-molecular reactions of nucleogenic phenyl cations with 1, 4-diazine derivatives." Chemistry of Heterocyclic Compounds 50, no. 11 (2015): 1595-1601. |
|
Venkatesh, Talavara, Yadav Dasharathrao Bodke, Muthipeedika Nibin Joy, Bhadrapura Lakkappa Dhananjaya, and Sivaramakrishnan Venkataraman. "Synthesis of some benzofuran derivatives containing pyrimidine moiety as potent antimicrobial agents." Iranian journal of pharmaceutical research: IJPR 17, no. 1 (2018): 75. |
|
Alam, Mohammad A., Kriti Arora, Shirisha Gurrapu, Sravan K. Jonnalagadda, Grady L. Nelson, Paul Kiprof, Subash C. Jonnalagadda, and Venkatram R. Mereddy. "Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents." Tetrahedron 72, no. 26 (2016): 3795-3801. |
|
Saini, Minaxi, Dinesh Kumar Mehta, Rina Das, and Gurnam Saini. "Recent advances in anti-inflammatory potential of pyridazinone derivatives." Mini reviews in medicinal chemistry 16, no. 12 (2016): 996-1012. |
|
Reddy, Dinesh S., Kallappa M. Hosamani, and Hirihalli C. Devarajegowda. "Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies." European journal of medicinal chemistry 101 (2015): 705-715. |
|
Martinez Carretero EE, Dalmasso AD, Duplancic Videla MA, Jauregui JA. Humulus scandens (Loureiro) Merrill (Cannabaceae): emerging invader in central-western Argentina. |
|
Cui W, Guo H, Cui H. Vanadium toxicity in the thymic development. Oncotarget. 2015 Oct 6;6(30):28661. |
|
Xu R, Watkinson LD, Carmack TL, Lever JR, Lever SZ. Synthesis, Sigma Receptor Binding Studies, and. |
|
Füredi A, Tóth S, Szebényi K, Pape VF, Türk D, Kucsma N, Cervenák L, Tóvári J, Szakács G. Identification and validation of compounds selectively killing resistant cancer: delineating cell line–specific effects from P-glycoprotein–induced toxicity. Molecular cancer therapeutics. 2017 Jan 1;16(1):45-56. |
|
Jaramillo AC, Al Saig F, Cloos J, Jansen G, Peters GJ. How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance. Cancer Drug Resist. 2018;1:6-29. |
|
Szakács G, Hall MD, Gottesman MM, Boumendjel A, Kachadourian R, Day BJ, Baubichon-Cortay H, Di Pietro A. Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance. Chemical reviews. 2014 Apr 23;114(11):5753-74. |
|
Medicinal Chemistry received 6627 citations as per Google Scholar report